Mirum Pharmaceuticals Inc (MIRM)
25.84
+0.24
(+0.94%)
USD |
NASDAQ |
May 03, 16:00
25.82
-0.02
(-0.08%)
After-Hours: 20:00
Mirum Pharmaceuticals Cash from Investing (Quarterly): -2.00M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.00M |
| September 30, 2023 | -182.76M |
| June 30, 2023 | 35.55M |
| March 31, 2023 | 42.02M |
| December 31, 2022 | 26.76M |
| September 30, 2022 | -79.53M |
| June 30, 2022 | 23.97M |
| March 31, 2022 | 36.50M |
| December 31, 2021 | 108.02M |
| September 30, 2021 | -2.237M |
| Date | Value |
|---|---|
| June 30, 2021 | -24.46M |
| March 31, 2021 | -32.78M |
| December 31, 2020 | -4.946M |
| September 30, 2020 | -18.91M |
| June 30, 2020 | 27.97M |
| March 31, 2020 | 33.76M |
| December 31, 2019 | -5.144M |
| September 30, 2019 | -64.19M |
| June 30, 2019 | -58.40M |
| March 31, 2019 | -0.044M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-182.76M
Minimum
Sep 2023
108.02M
Maximum
Dec 2021
-7.411M
Average
-2.237M
Median
Sep 2021
Cash from Investing (Quarterly) Benchmarks
| Vanda Pharmaceuticals Inc | -43.78M |
| Sarepta Therapeutics Inc | 218.80M |
| Puma Biotechnology Inc | -8.17M |
| Reneo Pharmaceuticals Inc | 39.78M |
| Tharimmune Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -16.62M |
| Cash from Financing (Quarterly) | 1.777M |
| Free Cash Flow | -91.05M |
| Free Cash Flow Per Share (Quarterly) | -0.4637 |
| Free Cash Flow to Equity (Quarterly) | -22.02M |
| Free Cash Flow to Firm (Quarterly) | -21.62M |
| Free Cash Flow Yield | -8.62% |